Trexquant Investment’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,925
| Closed | -$847K | – | 1894 |
|
|
2024
Q1 | $847K | Buy |
8,925
+5,810
| +187% | +$551K | 0.02% | 977 |
|
|
2023
Q4 | $278K | Buy |
+3,115
| New | +$278K | 0.01% | 1267 |
|
|
2023
Q3 | – | Sell |
-32,953
| Closed | -$2.74M | – | 1881 |
|
|
2023
Q2 | $2.74M | Buy |
32,953
+3,148
| +11% | +$262K | 0.07% | 392 |
|
|
2023
Q1 | $2.27M | Buy |
+29,805
| New | +$2.27M | 0.06% | 412 |
|
|
2022
Q2 | – | Sell |
-9,149
| Closed | -$822K | – | 1924 |
|
|
2022
Q1 | $822K | Sell |
9,149
-3,270
| -26% | -$294K | 0.04% | 555 |
|
|
2021
Q4 | $1.39M | Buy |
+12,419
| New | +$1.39M | 0.09% | 301 |
|
|
2021
Q1 | – | Sell |
-1,880
| Closed | -$265K | – | 1522 |
|
|
2020
Q4 | $265K | Sell |
1,880
-13,674
| -88% | -$1.93M | 0.03% | 761 |
|
|
2020
Q3 | $1.73M | Buy |
15,554
+3,838
| +33% | +$428K | 0.11% | 257 |
|
|
2020
Q2 | $1.31M | Buy |
+11,716
| New | +$1.31M | 0.09% | 314 |
|